Serum Institute of India gets DCGI nod for export of malaria vaccine to UK Ruchika Sharma30 Sept 2022 12:15 PM ISTThe malaria vaccine was designed at the Jenner Institute, University of Oxford, which collaborated with the SII in 2020 to manufacture and develop the...
Myocarditis developing after COVID-19 vaccination resolves with in 6 months: JACC Medha Baranwal28 Sept 2022 8:00 PM ISTUSA: Myocarditis development after mRNA vaccination against SARS-CoV-2 resolves, with MRI showing signs the myocarditis was resolving, at about six...
Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster for Children aged 5 through 11 years Ruchika Sharma27 Sept 2022 11:15 AM ISTCOMIRNATY (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute...
Moderna seeks USFDA nod for Omicron-targeted COVID vaccine for adolescents, children Ruchika Sharma25 Sept 2022 10:30 AM ISTUS: Moderna Inc said on Friday it has requested U.S. authorization for use of its Omicron-targeting COVID vaccine in adolescents and children.The...
Double dose influenza vaccination may not improve cardiopulmonary outcomes in acute coronary syndrome Jacinthlyn Sylvia19 Sept 2022 8:00 PM ISTBrazil: A new study conducted by Henrique Andrade R Fonseca and his team showed that receiving two doses of the influenza vaccine before discharge did...
Pfizer COVID vaccine approved for children as young as six months in Brazil Ruchika Sharma19 Sept 2022 1:30 PM ISTRio De Janeiro: Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between...
Booster dose of Malaria vaccine after three-dose regimen effective against clinical malaria Dr. Shravani Dali19 Sept 2022 11:00 AM ISTMalaria vaccine is still effective against spread of malaria according to a recent study published in the Lancet Infectious Diseases Malaria is a...
Novavax seeks updated Emergency Use Listing from WHO for Nuvaxovid as booster in adults Ruchika Sharma18 Sept 2022 12:30 PM ISTUS: Novavax has announced the submission of a request to the World Health Organization (WHO) to update the Emergency Use Listing (EUL) of Nuvaxovid...
Pfizer begins Phase 3 clinical trial of mRNA-based Influenza vaccine Ruchika Sharma15 Sept 2022 11:00 AM ISTNew York: Pfizer Inc. has announced that the first participants have been dosed in a pivotal Phase 3 clinical trial to evaluate the...
Novavax Nuvaxovid gets expanded conditional marketing authorization in EU for use as booster for adults aged 18 and older Ruchika Sharma14 Sept 2022 1:15 PM ISTGaithersburg: Biotechnology company, Novavax, Inc., has recently announced that the European Commission (EC) has approved the expanded conditional...
Valneva, VBI Vaccines ink pact for Hepatitis B vaccine PreHevbri Ruchika Sharma11 Sept 2022 5:15 PM ISTCambridge, Mass.: Valneva SE and VBI Vaccines Inc. have announced a partnership in select European markets for the marketing and distribution of...
Pfizer COVID vaccine approved for kids under 5 in Canada MD Bureau11 Sept 2022 3:46 PM ISTIt's the second vaccine approved for that age group after Health Canada approved Moderna's Spikevax in July.
